First PREMIER Bank’s Integra LifeSciences IART Stock Holding History

First PREMIER Bank’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-300	Closed	-$12K	–	356
2023 Q2	$12K	Hold	300	–	–	﹤0.01%	316
2023 Q1	$17K	Hold	300	–	–	0.01%	325
2022 Q4	$17K	Hold	300	–	–	0.01%	315
2022 Q3	$13K	Buy	+300	New	+$15.4K	﹤0.01%	335

Other funds holding IART

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First PREMIER Bank's IART Position: Q3 2023 in Review

First PREMIER Bank sold out of Integra LifeSciences (IART) in Q3 2023, closing a stake of 300 shares — an estimated $12K sold.

First PREMIER Bank first reported a position in IART in Q3 2022 and held it in 4 quarters. The position peaked at $17K in Q1 2023. 262 funds tracked by Wall St. Rank hold IART as of Q3 2023.

First PREMIER Bank reported no remaining Integra LifeSciences position as of Q3 2023 after selling out during the quarter.
First PREMIER Bank sold 300 Integra LifeSciences shares in Q3 2023, an estimated $12K.
First PREMIER Bank first reported a position in Integra LifeSciences in Q3 2022 and held it in 4 quarters.
First PREMIER Bank's Integra LifeSciences position peaked at $17K in Q1 2023.
262 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2023.

Based on First PREMIER Bank's 13F filing for Q3 2023, filed 16 Oct 2023.